Press releases

In reaction to European Commission proposals related to corporate tax, released on 22 December 2021, Chiara Putaturo, Oxfam’s EU Tax expert, said: “After almost two years into the global COVID-19 pandemic, that has increased inequality across Europe and poured billions of taxpayers' money into keeping businesses afloat, it’s high time that the European Commission proposes to make big companies pay more taxes."

Oxfam Pilipinas on Monday echoed local officials in Eastern Visayas calling for immediate assistance for survivors of Super Typhoon Rai (local name: Odette).

Nearly 90% of Somalia is now in a severe drought, following three consecutive failed rain seasons. Some areas facing their driest season in 40 years. Nearly 3.5 million people are already acutely food insecure and millions more are now at risk of going hungry by the beginning of next year.

Campaigners from the People’s Vaccine Alliance say the refusal of pharmaceutical companies to openly share their vaccine science and technology and the lack of action from rich countries to ensure access to vaccines globally have created the perfect breeding ground for new variants such as Omicron.

Oxfam International has accepted the resignation of its Board chair, Dr Jemilah Mahmood, who is leaving in order to focus on a new board role outside the sector. Deputy chair Nisreen Alami will assume the chair while Oxfam pursues a new appointment.

Humanitarian need is at its highest-ever level, and what is worse is that we have long known all the terrible causes behind it.

"This proposal weakens the fundamental rights of asylum seekers and strengthens Fortress Europe, and goes against everything that EU should stand for," said Erin McKay, European Migration Campaign Manager at Oxfam.   

A coalition of organizations has published a new database today revealing $38.2 billion worth of investment and financial relationships that involve 318 financial intermediary clients of Dutch development bank FMO and the World Bank’s private lending arm, the IFC. 

A new Oxfam report shows an undeniable increase in gender-based violence (GBV) during the COVID-19 pandemic around the world to which too many governments and donors are not doing enough to tackle.

In reaction to Pfizer’s announcement of voluntary licenses of its COVID-19 oral antiviral treatment Paxlovid to the Medicines Patent Pool, People’s Vaccine Alliance spokesperson and Oxfam America’s Senior Advocacy Advisor, Robbie Silverman, said: “Pfizer’s announcement to voluntarily licence the COVID treatment Paxlovid is welcome but is far from enough."